Skip to main content

Published locations for Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped

User login

  • Reset your password
  • /content/phase-3-studies-antiamyloid-alzheimers-drug-crenezumab-stopped
  • /clinicianreviews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /familypracticenews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /internalmedicinenews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /neurologyreviews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /psychiatry/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /internalmedicine/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /neurology/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug-crenezumab
  • /familymedicine/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers-drug
  • /clinicalneurologynews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers
  • /clinicalpsychiatrynews/article/193578/alzheimers-cognition/phase-3-studies-antiamyloid-alzheimers